FDA

Award-winning investigative reporter Laura Beil's 2019 podcast series 'Bad Batch' uncovers how Liveyon, a South Texas stem cell company, distributed contaminated products with no therapeutic benefit—revealing the darker side of a multibillion-dollar industry operating largely without oversight.